NORML

MARCH 30, 2020

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings.

CBD 304

CBD Clinical Trials Data Treatment 304

NORML

FEBRUARY 26, 2019

They look at this constantly, they look at the data, they look at the science and they make those recommendations to us on that basis.” When asked about the likelihood of the league changing its policies on the use of medical marijuana, Goodell answered, “We rely on our medical advisors to give us advice.

Access 203

Access Medicine Policy Media 203

NORML

AUGUST 20, 2019

The self-reported use of marijuana by teenagers continues to decline nationally, according to federal data reported by the United States Substance Abuse and Mental Health Services Administration (SAMHSA). The agency’s 2018 report finds that past-year marijuana use by those ages 12 to 17 has fallen consistently since 2002, from 15.8

Marijuana 242

Marijuana Data Access Environment 242

NORML

DECEMBER 29, 2020

According to statewide polling data, 90 percent of Kentucky residents support regulating medical marijuana access. The post States to Watch in 2021: Kentucky appeared first on NORML.

Data 246

Data Access Marijuana Cannabis 246

The Cannigma

APRIL 12, 2023

MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. In September 2021, MoreBetter hosted a self-reported data collection with this CBN tincture offered to participants for free of charge from CBDistillery. Back to our study.

Sleep 133

Sleep Data Tincture Research and Development 133

NORML

NOVEMBER 1, 2022

“Legalizing and regulating cannabis provides for more job opportunities, greater tax revenues, and safe access to high quality products at increasingly affordable prices,” NORML’s State Policy Manager Jax James said. This economic data shows once again why legalization is a preferable policy option over criminal prohibition.".

Legalization 49

Legalization Data Policy Access 49

Illinois News Joint

OCTOBER 10, 2024

The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. This growth has allowed for the creation of new jobs, increased access to cannabis for consumers, and shows the State’s commitment to social equity in its cannabis programs.”

Seed-To-Sale 111

Seed-To-Sale Data Dispensary Agriculture 111

NORML

JUNE 10, 2019

Military veterans who participate in a state’s medical marijuana access program frequently report substituting cannabis for alcohol and other controlled substances, according to data published in The American Journal of Drug and Alcohol Abuse. ”

Chronic Pain 275

Chronic Pain Access Collective Medicine 275

NORML

APRIL 7, 2020

Incidences of the vaping-related lung illness EVALI (e-cigarette or vaping product use-associated lung injury) are primarily concentrated to jurisdictions where adult-use cannabis consumption is prohibited, according to data published in the Journal of the American Medical Association (JAMA) Network Open.

Vaping 291

Vaping Legalization Concentrates Access 291

NORML

APRIL 27, 2020

The Coalition letter focuses on the need for small business access to the SBA relief funds as an avenue to protect the progress that has been made by minority entrepreneurs in the emerging legal cannabis marketplaces. You can read NORML’s factsheet on the racial disparity among arrests here. You can read the full letter below.

Business 316

Business Access Policy Programs 316

NORML

FEBRUARY 28, 2020

Patients purchased an estimated $112 million worth of medical cannabis-related products in 2019, according to newly released Maine tax data. Although the state’s medical cannabis access program has been operational for some two decades, Maine officials only began tracking caregiver-related tax revenue in February of 2019.

Data 241

Data Patients Retail Programs 241

Cannabis Law Report

JUNE 21, 2021

Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

Illinois News Joint

MARCH 24, 2025

The Illinois Department of Agriculture (IDOA) and the Division of Cannabis Regulation announced today an official Metrc implementation timeline for licensed cannabis businesses transitioning from BioTrack to Metrc as Illinois’ track-and-trace data system.

Supply Chain 90

Supply Chain Agriculture Packaging Dispensary 90

Cannabis Law Report

DECEMBER 18, 2020

15, 2020 /PRNewswire/ — CME Group, the world’s leading and most diverse derivatives marketplace, today announced that customers can now access hemp … Read More. The post CME Group Adds New Hemp Pricing Data to CME DataMine first appeared on Cannabis Law Report. CHICAGO , Dec.

Data 98

Data Hemp Access Law 98

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Nugg MD’s report suggests there is more to unpack when analyzing healthcare disparities related to MMJ access.

Access 98

Access Patients Chronic Pain Conditions 98

Canna Care Docs

OCTOBER 10, 2024

Rescheduling would ease those research barriers, improving access to data and education around the plant and opening the door to fully explore the medical benefits cannabis could provide. No matter the reason, we’re here to help you better understand and access medical cannabis. Contact us today to discuss your needs!

Patients 111

Patients DEA Research and Development Recreational 111

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 212

Clinical Trials Chronic Pain Data Treatment 212

Cannabis Law Report

AUGUST 8, 2021

A new poll, commissioned by the Canadian Psychedelic Association, has highlighted widespread support for legal access to psilocybin-assisted therapy among Canadians. The Canadian Psychedelic Association (CPA) has today released data from a telephone survey of over 1,000 Canadian adults.

Therapy 105

Therapy Access Legalization Education 105

NORML

AUGUST 29, 2019

” Specifically, federal and state data finds that teen cannabis use has declined in past years – during the same time that many states have legalized and regulated the use of cannabis by adults. According to an August 2019 federal report , past-year marijuana use by those ages 12 to 17 has fallen consistently since 2002, from 15.8

Education 236

Education Data Retail Environment 236

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 283

Clinical Trials Chronic Pain Cannabinoids Patients 283

Cannabis Life Network

SEPTEMBER 16, 2022

BDSA’s latest report suggests that recreational cannabis access affects longer standing medical market. Access with a medical card encourages patients to buy heavily taxed adult-use cannabis. But is recreational access a benefit or hinderance on medical cannabis?

Access 109

Access Recreational Patients Cannabis 109

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 258

Chronic Pain Therapy Patients Topical 258

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

Veriheal

DECEMBER 14, 2021

An Analysis of Nationwide EVALI Data. Acknowledging this data, the study’s authors called for states to consider initiating home cultivation policies. The post New Data Reveals Legal States Experienced Fewer Cases of EVALI appeared first on Cannabis Central.

Data 98

Data Vaping Legalization Consumption 98

NORML

FEBRUARY 1, 2019

According to data compiled by the US Centers for Disease Control, the drug was attributed to over 11,500 overdose deaths in 2017. In the first study , Canadian researchers assessed the relationship between cannabis and benzodiazepines in a cohort of 146 patients enrolled in the nation’s medical marijuana access program.

Patients 246

Patients Chronic Pain Therapy Data 246

NORML

JULY 2, 2019

Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs.

Retail 225

Retail Sleep History Medicine 225

Cannabis Law Report

AUGUST 10, 2021

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?

Data 98

Data Pharmaceutical Treatment Medicine 98

NORML

MAY 23, 2019

Seniors who report the use of cannabis over the past year say that it improves their overall quality of life, according to survey data published in the journal Gerontology & Geriatric Medicine. Researchers from the University of Colorado School of Medicine surveyed 274 older respondents (mean age = 72.5

Topical 210

Topical Data Edibles Medicine 210

Americans for Safe Access

MARCH 24, 2020

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

Cannabinoids 247

Cannabinoids Data Safety Patients 247

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One.

Chronic Pain 217

Chronic Pain Patients Therapy Data 217

NORML

JULY 17, 2019

Members of the United States Senate Committee on Banking, Housing, and Urban Affairs are scheduled to hear testimony next week regarding the need to provide greater access to financial services for state-licensed marijuana-related businesses. ” (Read NORML’s full testimony here.). .”

Banking 192

Banking Marijuana Legislation Access 192

NORML

JANUARY 24, 2019

Sixty-six percent of US adults believe that “the use of marijuana should be made legal,” according to national survey data compiled by the Gallup. ” Never in modern history has there existed greater public support for ending the nation’s nearly century-long experiment with marijuana prohibition.

History 196

History Legislation Data Policy 196

Canna Law Blog

MARCH 25, 2025

Several proposals aim to: Expand medicinal cannabis access. Data Privacy 29. What data privacy obligations do cannabis businesses have? Given the sensitive nature of medicinal cannabis information, businesses must comply with the Privacy Act 1988, including: Secure storage of patient data. Increase export opportunities.

Research and Development 88

Research and Development Medicine Compliance Compliance 88

Americans for Safe Access

JANUARY 12, 2024

ASA’s recommendation to FDA for scheduling can be found here.

DEA 130

DEA Media Access Data 130

Cannabis Law Report

AUGUST 23, 2021

Medicinal Cannabis Access Data Dashboard. To improve transparency and data accessibility, the TGA publishes de-identified data on the number of unapproved medicinal cannabis products accessed through the Special Access Scheme (SAS). Medicinal cannabis Special Access Scheme category B data.

Data 105

Data Access Medicine Patients 105

NORML

MAY 21, 2019

The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. ” In observational models , patients with legal access to cannabis typically reduce or eliminate their use of opioids.

Clinical Trials 199

Clinical Trials CBD History Data 199

SpeedWeed

JULY 18, 2021

The general population in states where cannabis is legal has very easy access to a wide array of high-potency cannabis products, including extremely high-potency cannabis concentrates which can exceed 90% THC, and we’ve been limited to studying the whole plant with under 10% THC.”. View original article.

Concentrates 98

Concentrates Data THC CBD 98